Inhibrx LP - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Inhibrx LP (Inhibrx) is a biotherapeutic company that develops drugs for treatment of oncology, infectious disease and inflammatory diseases. The companys products include therapeutic proteins with multivalent and multi specific molecules which are designed from their antibody technology. Its programs are based on comprehensive target discovery and selection expertise with its creative implementation for therapeutic research. The companys proprietary platforms enable fit-for-function biotherapeutics that interface with the biology of each target antigen and focus immune activation and mediate enhanced signalling. It also develops proprietary discovery and optimization platforms for conventional and single domain antibodies. Inhibrx is headquartered in La Jolla, California, the US.

Inhibrx LP - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Inhibrx LP, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Inhibrx LP, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Inhibrx LP, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Inhibrx LP, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Inhibrx LP, Medical Devices Deals, 2012 to YTD 2018 9
Inhibrx LP, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Inhibrx LP, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Inhibrx Raises USD410 Million in Venture Financing 11
Inhibrx Secures USD20 Million from Oxford Finance 12
Partnerships 13
Inhibrx and Alpha-1 Project Enter into Agreement 13
Licensing Agreements 14
Inhibrx Enters into Licensing Agreement with Celgene 14
Equity Offering 15
Inhibrx to Raise Funds through Private Placement of Shares 15
Inhibrx LP - Key Competitors 16
Inhibrx LP - Key Employees 17
Inhibrx LP - Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Clinical Trials 19
Oct 31, 2017: Inhibrx Wins CARB-X Award Of Up To $6.0M To Accelerate Development Of Its Novel Antibody, INBRX-111, To Treat Pseudomonas Infections 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List Of Tables


Inhibrx LP, Pharmaceuticals & Healthcare, Key Facts 2
Inhibrx LP, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Inhibrx LP, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Inhibrx LP, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Inhibrx LP, Deals By Therapy Area, 2012 to YTD 2018 8
Inhibrx LP, Medical Devices Deals, 2012 to YTD 2018 9
Inhibrx LP, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Inhibrx Raises USD410 Million in Venture Financing 11
Inhibrx Secures USD20 Million from Oxford Finance 12
Inhibrx and Alpha-1 Project Enter into Agreement 13
Inhibrx Enters into Licensing Agreement with Celgene 14
Inhibrx to Raise Funds through Private Placement of Shares 15
Inhibrx LP, Key Competitors 16
Inhibrx LP, Key Employees 17

List Of Figures


Xinjiang Goldwind Science & Technology Co Ltd, Performance Chart (2013 - 2017) 31
Xinjiang Goldwind Science & Technology Co Ltd, Ratio Charts 33
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals By Year, 2012 to YTD 2018 34
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals by Type, 2012 to YTD 2018 35

Inhibrx LP - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Inhibrx LP (Inhibrx) is a biotherapeutic company that develops drugs for treatment of oncology, infectious disease and inflammatory diseases. The companys products include therapeutic proteins with multivalent and multi specific

USD 250 View Report

Inhibrx LP - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Inhibrx LP (Inhibrx) is a biotherapeutic company that develops drugs for treatment of oncology, infectious disease and inflammatory diseases. The companys products include therapeutic proteins with multivalent and multi specific

USD 250 View Report

Miller Insurance Services LLP - Strategy, SWOT and Corporate Finance Report

Miller Insurance Services LLP - Strategy, SWOT and Corporate Finance ReportMiller Insurance Services LLP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information.

USD 175 View Report

Eversheds Sutherland (International) LLP - Strategic SWOT Analysis Review

Eversheds Sutherland (International) LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis,

USD 125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available